Yet, while their ability to reduce body weight and insulin levels was greater than GLP1 monotherapy in male models 33,34,35 , the potential of these GLP1-based multi-agonists for the treatment of the metabolic, hormonal, and gonadal complications associated with PCOS has not been explored to date
RELATED: Trump says GLP-1 weight-loss drugs coming at $50 for Medicare patients Further experiments showed that, once activated, the central amygdala reduced dopamine release into key hubs of the brains reward circuitry during hedonic feeding
Another benefit is the dosing flexibility
What are my biggest concerns about the side effects or long-term use
Real World Data Beyond Clinical Trials Clinical trials provide controlled environments with strict monitoring, but real world data captures how GLP-1 medications perform in everyday use
These elevations resolved without intervention in most cases